Thais Motria Sielecki
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$3.5MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $3.5M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jun 9, 2021 | NIH | STTR Phase II IND enabling development of LGM2605 as adjuvant treatment for asthma | $964K | Lignamed, LLC |
| Feb 15, 2021 | NIH | SBIR Phase II Optimization of LGM2605 for use as a device in lung transplant | $916K | Lignamed, LLC |
| Jun 29, 2020 | NIH | STTR Phase II IND enabling development of LGM2605 as adjuvant treatment for asthma | $1.0M | Lignamed, LLC |
| Aug 15, 2018 | NIH | SBIR Phase II Optimization of LGM2605 for use as a device in lung transplant | $300K | Lignamed, LLC |
| Jul 17, 2017 | NIH | STTR Phase I Effects of LGM2605 on a Primate Model of Asthma | $278K | Lignamed, LLC |
Peer ranks
Federal funding#526
Awards as PI#470
Patents#505
Companies
- Lignamed, LLCLinked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.